| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tricida, Inc. | Director | Stock Option (right to buy) | 27,207 | 15 Jun 2022 | Direct | ||
| scPharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 0 | 07 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SCPH | scPharmaceuticals Inc. | 07 Oct 2025 | 4 | $0 | 4 | Director | 07 Oct 2025, 16:30 |
| SCPH | scPharmaceuticals Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:43 |
| SCPH | scPharmaceuticals Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 17:00 |
| SCPH | scPharmaceuticals Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 16:15 |
| /report/000159558522000053-veitinger-klaus-r-dr-2022-06-15 | Tricida, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 16:28 |
| SCPH | scPharmaceuticals Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 15 Jun 2022, 16:30 |
| /report/000159558521000078-veitinger-klaus-r-dr-2021-06-10 | Tricida, Inc. | 10 Jun 2021 | 2 | $0 | 4 | Director | 11 Jun 2021, 17:11 |
| SCPH | scPharmaceuticals Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 16:46 |